ARQT icon

Arcutis Biotherapeutics

139 hedge funds and large institutions have $1.06B invested in Arcutis Biotherapeutics in 2022 Q3 according to their latest regulatory filings, with 35 funds opening new positions, 68 increasing their positions, 19 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
139
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
5
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$5.86M
Puts
$349K
Net Calls
Net Calls Change

Top Sellers

1 -$13.3M
2 -$9.18M
3 -$5.23M
4
Invesco
Invesco
Georgia
-$3.64M
5
Citadel Advisors
Citadel Advisors
Florida
-$2.14M
Name Holding Trade Value Shares
Change
Change in
Stake
101
$228K
102
$223K
103
$216K
104
$214K
105
$207K
106
$201K
107
$196K
108
$183K
109
$126K
110
$113K
111
$101K
112
$95K
113
$73K
114
$61K
115
$55K
116
$54K
117
$53.5K
118
$47.1K
119
$25K
120
$23K
121
$23K
122
$21K
123
$20K
124
$19K
125
$17K